Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s ...

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

Under Chancellor Friedrich Merz, Germany relationship with China is entering a phase of cautious recalibration in 2025.

At today's Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted convincingly in favor of all proposals by the Board ...

China's strategic investments in higher education, particularly through Project 985, have propelled its universities to ...

Qatar’s $526 billion sovereign wealth fund has received approval to acquire a 10 percent stake in China Asset Management Co. It is a rare Gulf investment into one of the country’s largest mutual fund ...

L’Oréal Groupe has backed Chinese biotech start-up Veminsyn to help identify new ingredients and speed up the process of ...